Atkins Michael B. 4
4 · Werewolf Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Atkins Michael B.
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-04+35,000→ 35,000 totalExercise: $5.25Exp: 2034-01-03→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option was granted on January 4, 2024. The shares underlying the option vest over three years, with one-third of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in equal monthly installments thereafter.